The joint venture – of which Quintiles will own 60 percent and Quest will own 40 percent – is poised to be the second largest central laboratory services firm in the world.

The draft document, which includes recommendations on which molecular tests labs should perform, on what samples, and with what analytical specifications, is available for comment until April 22.

Members of the Exome Aggregation Consortium have collected and done variant calling on more than 90,000 human exomes.

A group of 10 so-called PediSeeker volunteers from the Children's Hospital of Philadelphia interpreted secondary variants in PediSeq exomes.

Scientists from Edgewood Chemical Biological Center and Signature Science published the study this week in GigaScience.

By focusing on girls with severe autism, Johns Hopkins researchers uncovered four candidate genes for the disorder, including one involved in neuronal development and chromatin biology.

Metagenomic tools are shedding light on how microbes survive in and contribute to environments ranging from wetlands to natural oil seepage sites, according to presentations at this year's ABRF meeting.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment. 

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease. 

Mar
05
Sponsored by
SomaLogic

In this archived webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.